“Clinical and Translational Research in Multiple Myeloma: Novel Immunotherapies, Prognostic Biomarkers and Precision Medicine”

Participation in the design of prospective and retrospective clinical studies in multiple myeloma. Clinical data collection and research database management. Data evaluation of efficacy and safety of novel immunotherapeutic strategies, with particular focus on bispecific antibodies and other innovative immunotherapies. Correlation between clinical features, treatment response, circulating plasma cells characterization, measurable residual disease (MRD) and clinical outcomes. Collaboration with the translational research laboratory for integration of biological and clinical data. Statistical analysis and dissemination of results through scientific publications and presentations at national and international meetings.